RHUMADOL
Pierre Fabre Medicament
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79021452 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
| Law Office Assigned | L50 |
| Employee Name | MICHOS, JOHN E |
Timeline
| 2005-11-08 | Application Filed |
| 2006-11-17 | Abandon |
| 2006-12-18 | Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED |
| 2006-12-18 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  PIERRE FABRE MEDICAMENT |
| Entity Statement | Société par Actions Simplifiée |
| Address | 45 place Abel Gance F-92100 BOULOGNE BILLANCOURT FR |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely medicines used in the treatment of arthralgia (joint pain); dietetic substances adapted for medical use namely food supplements designed to relieve arthralgia (joint pain) |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | 2006-04-06 | 1 SDRC M: |
| NEW APPLICATION ENTERED IN TRAM | 2006-04-07 | 2 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2006-05-11 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2006-05-16 | 4 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2006-05-17 | 5 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2006-05-18 | 6 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2006-05-18 | 7 RFCS P: |
| REFUSAL PROCESSED BY IB | 2006-06-01 | 8 RFNT P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2006-12-07 | 9 CHLD M: |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2006-12-18 | 10 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2006-12-18 | 11 MAB2 O:Outgoing Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2007-07-05 | 12 NREP P: |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2007-09-06 | 13 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2007-09-12 | 14 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2007-09-27 | 15 OPNX P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2007-12-18 | 16 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2007-12-18 | 17 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2008-01-10 | 18 FINT P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2009-10-15 | 19 CHLD M: |
| INTERNATIONAL REGISTRATION RENEWED | 2009-10-23 | 20 RNWL P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2010-09-13 | 21 CHLD M: |
| DEATH OF INTERNATIONAL REGISTRATION | 2020-03-20 | 22 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2020-03-21 | 23 DENA O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RHUMADOL 79021452 not registered Dead/Abandoned |
PIERRE FABRE MEDICAMENT 2005-11-08 |
 RHUMADOL 78879746 not registered Dead/Abandoned |
PLANTES ET MEDECINES 2006-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 